Product Information
ZOLMITRIPTAN 5 MG NASAL SPRAY is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $41.2920 per EA under NDC 69238235206. Its NADAC has been published 90 times since Dec 4, 2024.
FDA first approved this application on Sep 30, 2003. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Zolmitriptan market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 mg/1
Manufacturer
Amneal Pharmaceuticals NY LLCNDC
69238235206
Classification
Generic
Dosage Form
SPRAY, METERED
Route
NASAL
Effective Date
8/19/2026
Active Ingredients
ZOLMITRIPTANApproval Type
Authorized Generic (NDA)
FDA Application
NDA021450FDA Approved
9/30/2003
TE Code
AB
On Market Since
7/15/2024
Pharmacological Classes
Price Statistics
The NADAC for ZOLMITRIPTAN 5 MG NASAL SPRAY has been published 90 times since Dec 4, 2024, and over the history we have for it it has declined 28.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $41.2920 per EA |
|---|---|
| All-time high | $60.6023 (Jan 15, 2025) |
| All-time low | $38.6728 (Nov 19, 2025) |
| 52-week high | $47.6290 |
| 52-week low | $38.6728 |
| Median price | $45.0121 |
| Average price | $46.4649 |
| Largest weekly change | -9.7% (Jan 22, 2025) |
| Weeks tracked | 90 |
| Tracking since | Dec 4, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ZOLMITRIPTAN 5 MG NASAL SPRAY?
The current National Average Drug Acquisition Cost (NADAC) for ZOLMITRIPTAN 5 MG NASAL SPRAY, manufactured by Amneal Pharmaceuticals NY LLC, is $41.2920 per EA (NDC 69238235206), effective Aug 19, 2026.
How has the price of ZOLMITRIPTAN 5 MG NASAL SPRAY changed over time?
Over the history we have for it, the NADAC for ZOLMITRIPTAN 5 MG NASAL SPRAY has declined 28.5%. It has been tracked across 90 weekly CMS publications since Dec 4, 2024.
What are the highest and lowest recorded NADAC prices for ZOLMITRIPTAN 5 MG NASAL SPRAY?
Since Dec 4, 2024, the NADAC for ZOLMITRIPTAN 5 MG NASAL SPRAY has ranged from a low of $38.6728 (Nov 19, 2025) to a high of $60.6023 (Jan 15, 2025), with a median of $45.0121 per EA.
Are there cheaper alternatives to ZOLMITRIPTAN 5 MG NASAL SPRAY?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ZOLMITRIPTAN 5 MG NASAL SPRAY in a comparable dosage form, but none are currently priced below it.
Who manufactures ZOLMITRIPTAN 5 MG NASAL SPRAY?
ZOLMITRIPTAN 5 MG NASAL SPRAY (NDC 69238235206) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.